C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof

Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
11/2007
11/22/2007	US20070269859 An isolated polynucleotide encoding a polypeptide having at least 90% sequence identity to SEQ ID NO:7 and having lecithin:cholesterolacyltransferase-like activity to alter sterol composition and oil production in plants and host cells; improved fatty acid, carotenoid, sterol and tocopherol; health
11/22/2007	CA2652043A1 Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
11/22/2007	CA2647102A1 Ras mutation and compositions and methods related thereto
11/20/2007	US7297772 Family of mammalian G protein-coupled heteromeric receptors that specifically bind and/or are specifically activated by sweet taste stimuli such as natural and artificial sweeteners and are expressed by recombinant host cells
11/20/2007	US7297771 Polypeptides having opioid receptor activity
11/20/2007	US7297768 PRO3574 polypeptide
11/20/2007	US7297766 PRO5337 polypeptides
11/20/2007	US7297765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2007	US7297760 Cancer associated protein
11/15/2007	WO2007128550A1 Biocompatible three dimensional matrix for the immobilization of biological substances
11/15/2007	WO2007128080A1 An assay for modulators of apoptosis
11/15/2007	WO2005120564A3 Vaccine compositions and methods
11/15/2007	US20070264686 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer treatment
11/14/2007	EP1853915A2 Method for detecting misfolded proteins and prions
11/14/2007	EP1212086B1 Immunological tolerance-induction agent
11/14/2007	CN101070381A Polymer containing nitrine
11/14/2007	CN100348618C Process for producing hydroxyalkyl starch derivatives
11/14/2007	CN100348616C Bt CrylA antibody, and its preparing method and special antigen and use
11/13/2007	US7294705 Anti-PRO3580 antibodies
11/13/2007	US7294703 Vectors with DNA encoding pro polypeptides
11/13/2007	US7294702 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2007	US7294693 Pro4428 Polypeptides
11/13/2007	US7294692 Vectors with DNA encoding pro polypeptides
11/13/2007	US7294495 PR03580 polypeptides
11/13/2007	US7294474 Cell-based functional assays and typically use cells, e.g., HEK-293 cells that stably express a G protein such as G alpha 15, G alpha 16 or gustducin; compounds identified are potentially useful as additives in compositions for human or animal consumption
11/13/2007	US7294335 PRO19645 antibodies
11/13/2007	CA2220169C Improved methods for the manufacture of magnetically responsive particles
11/08/2007	WO2007109118A3 RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS
11/08/2007	WO2007057778A3 Recombinant polypeptides and methods for detecting and/or quantifying autoantibodies against tsh receptor
11/08/2007	WO2007025388A3 Anti-apoptotic protein antibodies
11/08/2007	US20070260045 vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides
11/07/2007	EP1852443A1 Biocompatible three dimensional matrix for the immobilization of biological substances
11/07/2007	EP1852126A2 Vaccine for modulating between T1 and T2 immune responses
11/07/2007	EP1850878A2 C-terminally pegylated growth hormones
11/07/2007	CN101068553A Compositions and methods for treatment of neovascular diseases
11/06/2007	US7291717 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
11/06/2007	US7291716 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2007	US7291715 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
11/06/2007	US7291713 For modifying polypeptides
11/06/2007	US7291702 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
11/06/2007	US7291700 PRO4985 polypeptide
11/06/2007	US7291474 Hydrolytic substrates for an analyte-dependent enzyme activation system
11/06/2007	US7291329 Antibodies against PRO4406
11/06/2007	CA2010058C Storage of materials
11/01/2007	WO2007095506A8 Oligosaccharide modification and labeling of proteins
11/01/2007	WO2007030718A3 Omega-3 fatty acids encapsulated in zein coatings and food products incorporating the same
11/01/2007	WO2007030290A3 Cristin/r-spondin ligands active in the wnt signaling pathway and methods, compositions and kits relating thereto
11/01/2007	CA2800389A1 Glp-1 compounds
10/2007
10/31/2007	EP1697406A4 Protein separation device
10/31/2007	EP1011707B1 HIV-1 gp120 V1/V2 DOMAIN EPITOPES CAPABLE OF GENERATING NEUTRALIZING ANTIBODIES
10/31/2007	CN101062950A Polyethylene glycol modified thymus peptide 1 derivative
10/30/2007	US7288628 PRO20088 polypeptides
10/30/2007	US7288627 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for releasing tumor necrosis factor from blood; for modulating uptake of glucose by skeletal muscle cells; for stimulating release of proteoglycans from cartilage
10/30/2007	US7288626 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/30/2007	US7288394 Preferential patterning of biopolymers and cells on recessed and/or projecting surfaces for use biosensor in high throughput assays; drug screening
10/30/2007	US7288255 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells
10/25/2007	US20070248957 Encoded solid supports for biological processing and assays using same
10/24/2007	EP1846449A2 Irta-2 antibodies and their uses
10/24/2007	EP1846421A1 Water-soluble, surface-functionalized nanoparticle for bioconjugation via universal silane coupling
10/23/2007	US7285644 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2007	US7285636 Vectors with DNA encoding pro polypeptides
10/23/2007	US7285628 PRO1867 polypeptides
10/23/2007	US7285627 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
10/23/2007	US7285621 Multiple branch peptide construction
10/23/2007	US7285397 Gene expressing wasp poison allergen antigen 5 in bacteria in an insoluble form as inclusion bodies; denaturing using guanidine chloride without any reducing agent, and dialysis against acidic buffer; immunotherapy; genetic engineering
10/18/2007	WO2007117564A2 Clay-binding peptides and methods of use
10/18/2007	US20070243623 Device for the Presentation of Peptides or Proteins, Method for the Preparation and Use Thereof
10/18/2007	CA2648582A1 Conjugates of an anti-tnf-alpha antibody
10/18/2007	CA2648403A1 Soluble virus-specific t-cell receptor compositions
10/17/2007	EP1427758B1 Compositions and methods of treating diabetes
10/17/2007	CN101056647A Vasoactive intestinal polypeptide pharmaceuticals
10/17/2007	CN100343671C Method for identifying and extracting endotoxin
10/16/2007	US7282572 Method and device for improving protein stability and solubility
10/16/2007	US7282563 Opioid receptors and methods of use
10/16/2007	US7282561 PRO16090 polypeptides
10/16/2007	US7282560 PRO 4326 polypeptides
10/16/2007	US7282559 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2007	US7282558 PRO4329 polypeptide
10/16/2007	US7282476 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
10/11/2007	WO2007080197A3 Immobilised enzymes
10/11/2007	WO2007056227A3 Use of complement pathway inhibitors to treat ocular diseases
10/11/2007	US20070238150 Pro4356 polypeptides
10/10/2007	EP1002064B1 A modified polypeptide
10/10/2007	EP0666760B2 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS
10/10/2007	CN101052656A New chiral columns with broad chiral selectivity
10/10/2007	CN101050236A Immunogen by using mutant CRM197 of diphtheria toxin as carrier, preparation method, and application
10/10/2007	CN101050231A Method of using bare mica as substrate for developing protein crystal
10/10/2007	CN100341573C Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
10/09/2007	US7279552 Pro1782 polypeptides
10/09/2007	US7279318 Reacting the elements such as viruses and other micro-organisms with a synthetic hydrophilic multivalent polymer with a backbone based upon monomer units of N-2-hydroxypropylmethacrylamide, N-(2-Hydroxy ethyl)-L-Glutamine, ethyleneglycol-oligopeptide or dextran monomers and multiple reactive groups
10/09/2007	US7279165 Amyloid β1-6 antigen arrays
10/09/2007	CA2312296C Pasteurella multocida toxoid vaccines
10/09/2007	CA2156416C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
10/04/2007	WO2005014616A3 Complexes of gpcr142 and relaxin3 or insl5, and their production and use
10/04/2007	WO2004069193A3 Methods and compositions for inhibiting cholesterol uptake
10/03/2007	EP1839676A2 Erythropoietin derivates
10/03/2007	CN100340567C Triazoline artificial semi-antigen, antigen, specific antibody and use thereof
10/02/2007	US7276595 DNA sequence encoding a retinoic acid regulated protein
10/02/2007	US7276586 Antibodies to a polypeptide encoded by a nucleic acid under-expressed in stomach and lung tumor
10/02/2007	US7276581 Tyrosine kinases; phosphoproteins; antibodies; transgenic mice whose somatic or germ cells express tumors

1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 107